期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

正电子显像在心血管疾病中的研究现状和进展 被引量：1

Current Status and Advances of Using Positron Emission Tomography in Cardiovascular Disease
下载PDF
导出
摘要 正电子发射体层摄影术是一种无创性的探测生理性放射性核素在机体内分布的断层显像技术。正电子发射体层摄影术显像不仅广泛应用于肿瘤、神经精神系统等疾病的科学研究和临床工作,同时该技术也广泛应用于对各种心脏疾病的科学研究和临床实践中,如冠心病的诊断、冠心病严重程度的判断、存活心肌的检测、微血管疾病的评价和心脏交感神经功能的研究等。 Positron emission tomography （ PET ） is a non-invasive method to detect the distribution of radionuclide in vivo. PET is used in the diagnosis of cardiovascular disease, the assessment of the severity of cardiovascular disease, the detection of viable myocardium, the evaluation of microvascular disease and is also used to study myocardial sympathetic system widely.
作者 程旭 李殿富 黄钢
机构地区 南京医科大学第一附属医院核医学科 南京医科大学第一附属医院心脏科核医学科核心脏病学研究室 上海交通大学仁济医院核医学科上海交通大学临床核医学研究所
出处 《心血管病学进展》 CAS 2007年第1期68-70,共3页 Advances in Cardiovascular Diseases
关键词 体层摄影术 发射型计算机 单光子 心肌存活 脱氧葡萄糖 tomography emission computed viable myocardium deoxygiucose
分类号 R54 [医药卫生—心血管疾病] R817.4 [医药卫生—影像医学与核医学]
  • 相关文献

参考文献16

  • 1Bacharach SL,Bax JJ,Case J,et al.PET myocardial glucose metabolism and perfusion imaging:Part 1-Guidelines for data acquisition and patient preparation[J].J Nucl Cardiol,2003,10(5):543-556.
  • 2David W,Jonathan PJ,Jeffrey T,et al.PET/CT today and tomorrow[J].J Nucl Med,2004,45(suppl 1):4S-14S.
  • 3Klocke FJ,Baird MG,Lorell BH,et al.ACC/AHA/ASNC guidelines for theclinical use of cardiac radionuclide imaging--executive summary:A report of theAmerican College of Cardiology/American Heart Association Task Force onPractice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guide-lines for the Clinical Use of Cardiac Radionuclide Imaging)[J].J Am Coll Car-diol,2003,42(7):1318-1333.
  • 4Marwick TH,Shan K,Patel S,et al.Incremental value of rubidium-82 positron emission tomography for prognostic assessment of known or suspected coronary artery disease[J].Am J Cardiol,1997,80(7):865-870.
  • 5Schelbert HR,Beanlands R,Bengel F,et al.PET myocardial perfusion and glucose metabolism imaging:Part 2-Guidelines for interpretation and reporting[J].J Nucl Cardiol,2003,10(5):557-571.
  • 6Segall G.Assessment of myocardial viability by positron emission tomography[J].Nucl Med Commun,2002,23(4):323-330.
  • 7Bax JJ,Poldermans D,Elhendy A,et al.Sensitivity,specificity,and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium[J].Curr Probl Cardiol,2001,26(2):141-186.
  • 8Allman KC,Shaw LJ,Hachamovitch R,et al.Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction:a meta-analysis[J].J Am Coll Cardiol,2002,39(7):1151-1158.
  • 9Beanlands RS,Ruddy TD,de Kemp RA,et al.Positron emission tomography and recovery following revascularization (PARR-1):The importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function[J].J Am Coll Cardiol,2002,40(10):1735-1743.
  • 10Barrington SF,Chambers J,Hallett WA,et al.Comparison of sestamibi,thallium,echocardiography and PET for the detection of hibernating myocardium[J].Eur J Nucl Med Mol Imaging,2004,31(3):355-361.

同被引文献16

  • 1American Diabetes Association. National Diabetes Facl Sheel on Diabetes in the United States in 2002. http ://www. diabetes.org/diabetes-statistics/national-diabetes-fact-sheet.jsp.
  • 2Kang X,Berman DS,Lewin H,et al. Comparative ability of myocardial perfusion single-photon emission computed tomography to detect coronary artery disease in patients with and without diabetes mellitus [ J ]. Am Heart J, 1999,137 (5) :949-957.
  • 3Haffner SM,Lehto S, Ronnemaa T,et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction [ J ]. N Engl J Med, 1998,339 (4) :229-234.
  • 4Laskey V,K,Selzer F, Vlachos HA,et al. Comparison of in-hospital and one-year outcomes in patients with and without diabetes mellitus undergoing percutaneous catheter intervention (from the National Heart, Lung,and Blood Institute Dynamic Registry.) [J]. Am J Cardiol,2002,90(10) :1062-1076.
  • 5BARI Investigators. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status [ J ]. J Am Coll Cardiol,2000,35(5 ) : 1122-1129.
  • 6Kang X, Berman DS, Lekwin HC, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus[ J]. Am Heart J,1999,138 (6 Pt 1 ) :1025-1032.
  • 7Navare SM, Noble GL, Ahmed SU, et al. Risk stratification of diabetic patients with rest/stress ECG-gated Tc-99m sestamihi SPECT imaging: significance of mild perfusion abnormalities[J].J Am Coil Cardiol,2004,43 (5) :339.
  • 8Giri S,Shaw LJ,Murthy DR,et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease[J].Circulation,2002,105 ( 1 ) : 32-40.
  • 9Noble GI.. Navare SM,Hussain SA, et al. Progression of coronary artery disease in diabetics demonstraled by single isotope rest/stress Tc-99m sestamibi myocardial periusion imaging:more rapid than non-diabetics[J]? J Am Coil Cardiol,2004,43(5 ) :340.
  • 10Hayes SW, Schisterman EF, Lewin HC, et al. Gated myocardial perfusion SPECT has incremental value for predicting cardiac death in diabetic patients[J].J Am Coil Cardiol,2001,37(2) :381.

引证文献1

心血管病学进展
2007年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部